Published in Proc Natl Acad Sci U S A on September 15, 1998
Accumulation of intraneuronal Abeta correlates with ApoE4 genotype. Acta Neuropathol (2010) 0.96
Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice. Behav Pharmacol (2010) 0.92
Imaging the Alzheimer brain. J Alzheimers Dis (2011) 0.83
Acetylcholine receptor and behavioral deficits in mice lacking apolipoprotein E. Neurobiol Aging (2009) 0.81
Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice. Psychopharmacology (Berl) (2016) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it". Neurobiol Aging (1992) 9.39
Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem (1991) 8.81
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet (1994) 7.07
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature (1995) 6.62
The Golgi apparatus (complex)-(1954-1981)-from artifact to center stage. J Cell Biol (1981) 6.54
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 5.68
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Progress in unraveling pathways of Golgi traffic. Annu Rev Cell Biol (1985) 5.03
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47
Genetic associations with human longevity at the APOE and ACE loci. Nat Genet (1994) 4.17
Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol (1983) 3.19
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Protection against Alzheimer's disease with apoE epsilon 2. Lancet (1994) 2.96
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol (1994) 2.24
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci (1994) 1.92
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A (1995) 1.91
Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol (1994) 1.84
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci (1997) 1.73
Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol (1993) 1.72
Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol (1995) 1.66
A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet (1998) 1.63
MG-160. A novel sialoglycoprotein of the medial cisternae of the Golgi apparatus [published eeratum appears in J Biol Chem 1989 Mar 5;264(7):4264]. J Biol Chem (1989) 1.62
Single-day apolipoprotein E genotyping. J Neurosci Methods (1994) 1.59
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res (1987) 1.49
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem (1994) 1.40
Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience (1984) 1.38
Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology (1994) 1.35
Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res (1983) 1.29
Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet (1995) 1.17
Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol (1992) 1.08
Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus. J Histochem Cytochem (1990) 1.06
Evidence that all newly synthesized proteins destined for fast axonal transport pass through the Golgi apparatus. J Cell Biol (1982) 1.04
Familial Alzheimer's chromosome 14 mutations. Nat Med (1995) 1.02
Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci (1996) 1.00
Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience (1993) 1.00
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience (1986) 0.94
Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience (1996) 0.93
Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol (1996) 0.91
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci Lett (1997) 0.89
The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. Neuroreport (1996) 0.88
Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res (1993) 0.87
Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol Sci (1987) 0.86
Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and the intermediate compartment to the Golgi complex. Eur J Cell Biol (1995) 0.85
Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol Aging (1989) 0.85
Decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. J Neuropathol Exp Neurol (1995) 0.83
Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience (1994) 0.82
Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells. Brain Res (1997) 0.81
Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neurosci Lett (1995) 0.78
Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging (2001) 3.06
A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64
The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev (2007) 1.94
The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res (1985) 1.87
Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry (2008) 1.78
Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int (1999) 1.77
Oxytocin deficiency at delivery with epidural analgesia. Br J Obstet Gynaecol (1983) 1.77
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry (1990) 1.74
Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry (1997) 1.71
Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology (1994) 1.60
Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60
Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry (1996) 1.54
The vasopressinergic innervation of the brain in normal and castrated rats. J Comp Neurol (1985) 1.45
Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol (1975) 1.43
The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease. Acta Psychiatr Scand (2011) 1.43
Positive regulation of jun/AP-1 by E1A. Mol Cell Biol (1991) 1.32
Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry (1995) 1.29
Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res (1978) 1.29
A sexually dimorphic nucleus in the human brain. Science (1985) 1.27
Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials. Prog Brain Res (1992) 1.26
Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry (1996) 1.22
Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci (2001) 1.22
The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics (1998) 1.21
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol (2001) 1.19
VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging (1996) 1.18
Apoptosis during sexual differentiation of the bed nucleus of the stria terminalis in the rat brain. J Neurobiol (2000) 1.17
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16
A new actigraph for long-term registration of the duration and intensity of tremor and movement. IEEE Trans Biomed Eng (1998) 1.15
Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Ment Health (2005) 1.13
Senescence, sleep, and circadian rhythms. Ageing Res Rev (2002) 1.13
Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. J Neural Transm (1975) 1.11
Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol (2002) 1.11
Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging (1990) 1.10
Patterns of caregiver experiences among partners of cancer patients. Gerontologist (2000) 1.09
Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin. Brain (2007) 1.09
Autonomic function in hypertensive and normotensive subjects: the importance of gender. Hypertension (2001) 1.08
Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol (2000) 1.07
Ontogeny of the vasopressinergic neurons of the suprachiasmatic nucleus and their extrahypothalamic projections in the rat brain--presence of a sex difference in the lateral septum. Brain Res (1981) 1.07
Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res (1994) 1.07
Can specificity ever be proved in immunocytochemical staining. J Histochem Cytochem (1977) 1.07
Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain (1995) 1.05
Immuno-electron microscopical demonstration of vasopressin and oxytocin synapses in the limbic system of the rat. Cell Tissue Res (1979) 1.05
Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol (2000) 1.04
Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms (1997) 1.03
Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab (1997) 1.03
Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol (2010) 1.02
Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab (1999) 1.02
The sexually dimorphic nucleus of the preoptic area in the human brain: a comparative morphometric study. J Anat (1989) 1.00
Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav Brain Res (1993) 0.99
Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. Rev Neurosci (2007) 0.99
DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol (1997) 0.97
Microwave-enhanced in situ end-labeling of fragmented DNA: parametric studies in relation to postmortem delay and fixation of rat and human brain. J Histochem Cytochem (1995) 0.96
A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol Psychiatry (2006) 0.95
Prevalence of low back pain and concurrent psychological distress over a 16-year period. Occup Environ Med (2008) 0.95
Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol (2001) 0.95
Changes in vasopressin cells of the rat suprachiasmatic nucleus with aging. Brain Res (1987) 0.95
Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab (1998) 0.94
Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect. J Clin Endocrinol Metab (1998) 0.94
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease. Ann Neurol (1999) 0.94
Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res (1997) 0.94
Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience (1996) 0.93
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience (2011) 0.92
The ubiquitin-activating enzyme E1-like protein in lung cancer cell lines. Int J Cancer (2000) 0.92
Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. J Affect Disord (2012) 0.91
Sexual dimorphism of the human brain: myth and reality. Exp Clin Endocrinol (1991) 0.91
Vasopressin and oxytocin: distribution and putative functions in the brain. Prog Brain Res (1983) 0.91
Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol (1993) 0.91
Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis Assoc Disord (1998) 0.91
Walking the line: a randomised trial on the effects of a short term walking programme on cognition in dementia. J Neurol Neurosurg Psychiatry (2009) 0.90
Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 0.90
The Netherlands brain bank--a clinico-pathological link in aging and dementia research. J Neural Transm Suppl (1993) 0.90
Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol Aging (2001) 0.90
The presence of biologically labile compounds during ischemia and their relationship to the EEG in rat cerebral cortex and hypothalamus. J Neurochem (1972) 0.89
Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: sex differences and age-dependent changes. J Anat (1988) 0.88
Gravitational artefact in frequency spectra of movement acceleration: implications for actigraphy in young and elderly subjects. J Neurosci Methods (1996) 0.88
P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Exp Neurol (2000) 0.88
Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits. Exp Neurol (2000) 0.88
Long-term effects of cranial irradiation for childhood malignancy on sleep in adulthood. Eur J Endocrinol (2004) 0.88
Alzheimer's disease and NGF signaling. J Neural Transm (Vienna) (2004) 0.88
Vasoactive intestinal polypeptide neuron changes in the senile rat suprachiasmatic nucleus. Neurobiol Aging (1988) 0.88
Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog Brain Res (1992) 0.88
Extrahypothalamic vasopressin and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res (1986) 0.88
Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res (1990) 0.88
Rescheduling a three shift system at a steel rolling mill: effects of a one hour delay of shift starting times on sleep and alertness in younger and older workers. Occup Environ Med (1996) 0.88
Testosterone fails to reverse spatial memory decline in aged rats and impairs retention in young and middle-aged animals. Behav Neural Biol (1990) 0.88
Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res (1993) 0.87
A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. EMBO J (1992) 0.87
Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry (2001) 0.87
Vasopressin and oxytocin levels during normal pregnancy: effects of chronic dietary sodium restriction. J Endocrinol (1997) 0.87
False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol (1996) 0.87
Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease. Arch Gen Psychiatry (1999) 0.87
Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock. J Comp Neurol (2001) 0.87
Intercellular exchange of lysosomal enzymes: enzyme assays in single human fibroblasts after co-cultivation. Biochem Biophys Res Commun (1976) 0.86
Recovery of axonal transport in "dead neurons". Lancet (1998) 0.86
Hypothalamic oxytocin mRNA expression and melancholic depression. Mol Psychiatry (2007) 0.86
Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport (1997) 0.86
Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus. Neuroscience (1993) 0.86
Immunoelectronmicroscopic localization of vasopressin in the rat suprachiasmatic nucleus. Cell Tissue Res (1978) 0.85
Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease. Neuroendocrinology (2008) 0.85
Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. J Biol Chem (1993) 0.85